Colistin resistance mutations in phoQ can sensitize Klebsiella pneumoniae to IgM-mediated complement killing. 2023

Sjors P A van der Lans, and Manon Janet-Maitre, and Frerich M Masson, and Kimberly A Walker, and Dennis J Doorduijn, and Axel B Janssen, and Willem van Schaik, and Ina Attrée, and Suzan H M Rooijakkers, and Bart W Bardoel
Department of Medical Microbiology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.

Due to multi-drug resistance, physicians increasingly use the last-resort antibiotic colistin to treat infections with the Gram-negative bacterium Klebsiella pneumoniae. Unfortunately, K. pneumoniae can also develop colistin resistance. Interestingly, colistin resistance has dual effects on bacterial clearance by the immune system. While it increases resistance to antimicrobial peptides, colistin resistance has been reported to sensitize certain bacteria for killing by human serum. Here we investigate the mechanisms underlying this increased serum sensitivity, focusing on human complement which kills Gram-negatives via membrane attack complex (MAC) pores. Using in vitro evolved colistin resistant strains and a fluorescent MAC-mediated permeabilization assay, we showed that two of the three tested colistin resistant strains, Kp209_CSTR and Kp257_CSTR, were sensitized to MAC. Transcriptomic and mechanistic analyses focusing on Kp209_CSTR revealed that a mutation in the phoQ gene locked PhoQ in an active state, making Kp209_CSTR colistin resistant and MAC sensitive. Detailed immunological assays showed that complement activation on Kp209_CSTR in human serum required specific IgM antibodies that bound Kp209_CSTR but did not recognize the wild-type strain. Together, our results show that developing colistin resistance affected recognition of Kp209_CSTR and its killing by the immune system.

UI MeSH Term Description Entries
D007075 Immunoglobulin M A class of immunoglobulin bearing mu chains (IMMUNOGLOBULIN MU-CHAINS). IgM can fix COMPLEMENT. The name comes from its high molecular weight and originally was called a macroglobulin. Gamma Globulin, 19S,IgM,IgM Antibody,IgM1,IgM2,19S Gamma Globulin,Antibody, IgM
D007710 Klebsiella Infections Infections with bacteria of the genus KLEBSIELLA. Infections, Klebsiella,Infection, Klebsiella,Klebsiella Infection
D007711 Klebsiella pneumoniae Gram-negative, non-motile, capsulated, gas-producing rods found widely in nature and associated with urinary and respiratory infections in humans. Bacillus pneumoniae,Bacterium pneumoniae crouposae,Hyalococcus pneumoniae,Klebsiella pneumoniae aerogenes,Klebsiella rhinoscleromatis
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D003091 Colistin Cyclic polypeptide antibiotic from Bacillus colistinus. It is composed of Polymyxins E1 and E2 (or Colistins A, B, and C) which act as detergents on cell membranes. Colistin is less toxic than Polymyxin B, but otherwise similar; the methanesulfonate is used orally. Polymyxin E,Colimycin,Colisticin,Colistin Sulfate,Coly-Mycin,Totazina,Sulfate, Colistin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D001426 Bacterial Proteins Proteins found in any species of bacterium. Bacterial Gene Products,Bacterial Gene Proteins,Gene Products, Bacterial,Bacterial Gene Product,Bacterial Gene Protein,Bacterial Protein,Gene Product, Bacterial,Gene Protein, Bacterial,Gene Proteins, Bacterial,Protein, Bacterial,Proteins, Bacterial
D024881 Drug Resistance, Bacterial The ability of bacteria to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance, Bacterial,Antibacterial Drug Resistance

Related Publications

Sjors P A van der Lans, and Manon Janet-Maitre, and Frerich M Masson, and Kimberly A Walker, and Dennis J Doorduijn, and Axel B Janssen, and Willem van Schaik, and Ina Attrée, and Suzan H M Rooijakkers, and Bart W Bardoel
June 1992, Infection and immunity,
Sjors P A van der Lans, and Manon Janet-Maitre, and Frerich M Masson, and Kimberly A Walker, and Dennis J Doorduijn, and Axel B Janssen, and Willem van Schaik, and Ina Attrée, and Suzan H M Rooijakkers, and Bart W Bardoel
January 2017, The Lancet. Infectious diseases,
Sjors P A van der Lans, and Manon Janet-Maitre, and Frerich M Masson, and Kimberly A Walker, and Dennis J Doorduijn, and Axel B Janssen, and Willem van Schaik, and Ina Attrée, and Suzan H M Rooijakkers, and Bart W Bardoel
November 2010, American journal of respiratory cell and molecular biology,
Sjors P A van der Lans, and Manon Janet-Maitre, and Frerich M Masson, and Kimberly A Walker, and Dennis J Doorduijn, and Axel B Janssen, and Willem van Schaik, and Ina Attrée, and Suzan H M Rooijakkers, and Bart W Bardoel
July 2014, International journal of antimicrobial agents,
Sjors P A van der Lans, and Manon Janet-Maitre, and Frerich M Masson, and Kimberly A Walker, and Dennis J Doorduijn, and Axel B Janssen, and Willem van Schaik, and Ina Attrée, and Suzan H M Rooijakkers, and Bart W Bardoel
May 2020, Antimicrobial agents and chemotherapy,
Sjors P A van der Lans, and Manon Janet-Maitre, and Frerich M Masson, and Kimberly A Walker, and Dennis J Doorduijn, and Axel B Janssen, and Willem van Schaik, and Ina Attrée, and Suzan H M Rooijakkers, and Bart W Bardoel
September 2022, Cells,
Sjors P A van der Lans, and Manon Janet-Maitre, and Frerich M Masson, and Kimberly A Walker, and Dennis J Doorduijn, and Axel B Janssen, and Willem van Schaik, and Ina Attrée, and Suzan H M Rooijakkers, and Bart W Bardoel
September 2016, The Lancet. Infectious diseases,
Sjors P A van der Lans, and Manon Janet-Maitre, and Frerich M Masson, and Kimberly A Walker, and Dennis J Doorduijn, and Axel B Janssen, and Willem van Schaik, and Ina Attrée, and Suzan H M Rooijakkers, and Bart W Bardoel
July 2018, The Journal of antimicrobial chemotherapy,
Sjors P A van der Lans, and Manon Janet-Maitre, and Frerich M Masson, and Kimberly A Walker, and Dennis J Doorduijn, and Axel B Janssen, and Willem van Schaik, and Ina Attrée, and Suzan H M Rooijakkers, and Bart W Bardoel
January 2023, Frontiers in microbiology,
Sjors P A van der Lans, and Manon Janet-Maitre, and Frerich M Masson, and Kimberly A Walker, and Dennis J Doorduijn, and Axel B Janssen, and Willem van Schaik, and Ina Attrée, and Suzan H M Rooijakkers, and Bart W Bardoel
November 2017, Antimicrobial agents and chemotherapy,
Copied contents to your clipboard!